08/23/2024 4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 6:15 PM | Cellectar Biosciences (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
08/13/2024 5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/23/2024 11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
07/23/2024 5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/22/2024 5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 4:37 PM | Cellectar Biosciences (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
|
07/11/2024 4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 3:46 PM | Cellectar Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/16/2024 5:05 AM | Cellectar Biosciences (Filer)
| Form DEFR14A | |
05/14/2024 5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 5:32 AM | Cellectar Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 3:58 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/26/2024 3:59 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/25/2024 7:01 PM | Cellectar Biosciences (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
03/27/2024 5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 5:30 AM | Cellectar Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 7:31 PM | Cellectar Biosciences (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024 2:23 PM | Cellectar Biosciences (Subject) LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/07/2024 5:58 PM | Cellectar Biosciences (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024 5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 7:00 AM | ADAR1 Partners, LP (Filed by) Cellectar Biosciences (Subject)
| Form SC 13G | |
01/09/2024 5:02 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 7:04 PM | CARUSO JAMES V (Reporting) Cellectar Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:04 PM | Cellectar Biosciences (Issuer) Longcor Jarrod (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:05 PM | Cellectar Biosciences (Issuer) Shustov Andrei (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:07 PM | Cellectar Biosciences (Issuer) Kolean Chad J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:09 PM | Cellectar Biosciences (Issuer) Lea Darrell Shane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 4:15 PM | Cellectar Biosciences (Subject) LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
12/05/2023 5:01 AM | Cellectar Biosciences (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
11/29/2023 3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 5:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 6:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
10/27/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 3:54 PM | Cellectar Biosciences (Filer)
| Form S-3/A | |
10/05/2023 3:45 PM | Cellectar Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/02/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
09/22/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form PRE 14A | |
09/22/2023 3:30 PM | Cellectar Biosciences (Filer)
| Form D Notice of Exempt Offering of Securities | |
09/08/2023 4:17 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |